This 18-month feasibility study was funded by NHS England, commissioned by the Healthcare Quality Improvement Partnership (HQIP), and ran from January 2015 to July 2016. It was designed to specify the key elements required for a sustainable, national information system to collect information from the Child Death Reviews which are carried out in England by Child Death Overview Panels (CDOPs) and from the Child Death Review process currently being developed in Scotland. It was delivered by the University of Oxford, The National Perinatal Epidemiology Unit (NPEU) & University of Leicester.
Read it here
These new guidelines have been published by a multi-agency working group convened by The Royal College of Pathologists (RCPath) and The Royal College of Paediatrics and Child Health (RCPCH). They provide a protocol for the handling of sudden infant death, make recommendations to each profession and outline best practice for each part of the investigation process.
Image source: Pixabay
Responding to the publication, Dr Max Davie, Assistant Officer for Health Promotion for the Royal College of Paediatrics and Child Health (RCPCH), said:
“After years of campaigning we are very pleased to see Government moving forward with this draft legislation.
“The sugary drinks that will be affected by this tax have no nutritional benefit and often contain levels of sugar that are above a child’s daily recommended limit…”
Published by Royal College of Paediatrics and child Health, December 5th 2016
Image Source: Public Health England
These reports describe the importance of mental health and wellbeing among children and young people and the case for investment in mental health. They also summarise the evidence of what works to improve mental health among children and young people in order to inform local transformation of services.
Public Health England, 6th December 2016
This systematic review is part of a series of associated Cochrane reviews on interventions for obese children and adolescents and has shown that pharmacological interventions (metformin, sibutramine, orlistat and fluoxetine) may have small effects in reduction in BMI and bodyweight in obese children and adolescents. However, many of these drugs are not licensed for the treatment of obesity in children and adolescents, or have been withdrawn.
Cochrane Library, 29th November 2016
Thirty-five children (39%) developed one or more complications at some time during follow-up, including airway compromise, compression, or functional impairment; lesion ulceration; visual obstruction or ocular compression; and infection.
Paediatric News, December 7, 2016
Image source: Pixabay
In this article we lay out factors that bear on the success of clinical consultations and the maintenance of the essential clinician–parent relationship at progression or deterioration of life-limiting conditions or life-threatening illnesses.
Archives of Diseases in Children, 5th December 2016 (Open Access).